You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alkylating, alkylating agents

Showing 1 - 25 of 5,570
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

Gliomas Trial in Miami, Boston, New York (Nivolumab)

Active, not recruiting
  • Gliomas
  • Miami, Florida
  • +3 more
May 5, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Breast Cancer Trial in Amsterdam (carboplatin, thiotepa, and cyclophosphamide, chemo (docetaxel, doxorubicin, cyclofosfamide,

Recruiting
  • Breast Cancer
  • carboplatin, thiotepa, and cyclophosphamide
  • chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
  • Amsterdam, Netherlands
    NKI-AVL
Mar 21, 2022

Glioma, Glioblastoma Trial in Norway, Sweden (Disulfiram, Copper, Alkylating Agents)

Completed
  • Glioma
  • Glioblastoma
  • Trondheim, Norway
  • +7 more
Mar 16, 2021

Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker

Completed
Has Results
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 18, 2022

Cancer, Toxicity Due to Chemo, Sarcoma Trial in Le Kremlin Bicêtre (Triptorelin (GnRHa) + Chemotherapy)

Unknown status
  • Cancer
  • +5 more
  • Triptorelin (GnRHa) + Chemotherapy
  • Le Kremlin Bicêtre, France
    AP-HP, Bicêtre Hospital
Dec 16, 2019

Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem

Active, not recruiting
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Feb 28, 2022

Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

Recruiting
  • Hematological Malignancies
  • +3 more
  • Phoenix, Arizona
  • +19 more
Apr 12, 2022

Glioblastoma Multiforme Trial in Barcelona, Madrid (Tinostamustine)

Recruiting
  • Glioblastoma Multiforme
  • Barcelona, Spain
  • +1 more
Jul 18, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Tampa (Cisplatin, Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cisplatin
  • Stereotactic Body Radiation Therapy (SBRT)
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022

Breast Cancer Trial in Amsterdam (Intensified Cyclophophamide, Carboplatin and Thiotepa, dose dense adriamycine and

Terminated
  • Breast Cancer
  • Intensified Cyclophophamide, Carboplatin and Thiotepa
  • dose dense adriamycine and cyclophosphamide
  • Amsterdam, Netherlands
    NKI-AVL
Jan 20, 2021

High Grade Glioma, Brain Cancer Trial in France (Nivolumab)

Completed
  • High Grade Glioma
  • Brain Cancer
  • Bordeaux, France
  • +6 more
Dec 13, 2021

Breast Cancer Trial in Netherlands (Carboplatin and Paclitaxel, Doxorubicin, cyclophosphamide, Doxorubicin, cyclophosphamide,

Active, not recruiting
  • Breast Cancer
  • Carboplatin and Paclitaxel
  • +2 more
  • Alkmaar, Netherlands
  • +13 more
Oct 18, 2021

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • +5 more
  • Purified regulatory T-cells (Treg) plus CD34+ HSPC
  • +7 more
  • Stanford, California
    Stanford University
Oct 28, 2021

Drug Induced Neuropathy in Children With ALL

Recruiting
  • Acute Lymphocytic Leukemia
    • Trieste, Friuli Venezia Giulia, Italy
      IRCCS materno infantile Burlo Garofolo
    Mar 31, 2023

    Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and

    Recruiting
    • Acute Myeloid Leukemia (AML) in Remission
    • Stem Cell Transplantation
    • busulfan, cyclophosphamide and melphalan, BuCyMel
    • clofarabine, fludarabine and busulfan, CloFluBu
    • Brussels, Belgium
    • +16 more
    Jul 25, 2022

    Breast Cancer Trial in France, Netherlands (ddAC-CP-Olaparib, ddAC-mini CTC)

    Recruiting
    • Breast Cancer
    • Marseille, France
    • +10 more
    Oct 11, 2022

    Small-cell Lung Cancer, Soft Tissue Sarcoma, Triple-negative Breast Cancer Trial in Canada, United States (Tinostamustine

    Recruiting
    • Small-cell Lung Cancer
    • +4 more
    • Tinostamustine (EDO-S101)
    • Los Angeles, California
    • +7 more
    Dec 22, 2020

    Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)

    Recruiting
    • Rectal Cancer
    • External-beam radiation
    • +2 more
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Jan 25, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

    Completed
    • Metastatic Colorectal Cancer
    • Milan, MI, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Apr 1, 2022

    Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

    Not yet recruiting
    • Ovarian Cancer
    • Maywood, Illinois
      Loyola University Medical Center
    Aug 1, 2023

    HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

    Recruiting
    • HER2 Positive Early Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Jun 6, 2023